Literature DB >> 9245950

Urinary neutral endopeptidase in workers exposed to cadmium: interaction with cigarette smoking.

J Nortier1, A Bernard, H Roels, M Deschodt-Lanckman, C Gueuning, R Lauwerys.   

Abstract

OBJECTIVES: Structural impairment of the renal proximal tubular epithelium induced by cadmium (Cd) was investigated by measuring the concentration of neutral endopeptidase 24.11 (NEP), an ectoenzyme of the apical brush border, in the urine of 106 male workers employed in a Cd smelter (among whom 52 were occupationally exposed to Cd), and by comparing it with other tubular markers (low molecular weight proteins, lysosomal enzymes).
METHODS: NEP (EC 3.4.24.11), beta-N-acetyl-glucosaminidase (NAG) (EC 3.2.1.30), and NAG-B isoenzyme activities were measured by fluorimetric assays, whereas the concentrations of retinol binding protein (RBP), beta 2-microglobulin (beta 2M), and Clara cell protein (CC16) were measured by automated latex agglutination techniques.
RESULTS: An increased urinary excretion of NEP as well as microproteins was found only in subjects excreting more than 5 micrograms Cd/g creatinine. In this group, NEP concentrations were significantly higher in the subjects who smoked. This significant interaction could not be found for any other marker tested.
CONCLUSIONS: The data suggest that NEP enzymuria is high even at low exposures to Cd (with a threshold of urinary cadmium excretion (U-Cd) at 5 micrograms/g creatinine), indicating early structural alterations. Moreover, its particular sensitivity to smoking could be useful in the detection of new population clusters potentially more susceptible to development of nephrotoxic insult.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245950      PMCID: PMC1128804          DOI: 10.1136/oem.54.6.432

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  24 in total

1.  Role of microfilaments in maintenance of proximal tubule structural and functional integrity.

Authors:  P S Kellerman; R A Clark; C A Hoilien; S L Linas; B A Molitoris
Journal:  Am J Physiol       Date:  1990-08

Review 2.  Glutathione: toxicological implications.

Authors:  D J Reed
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

3.  Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-stage renal failure.

Authors:  M Deschodt-Lanckman; F Michaux; E De Prez; D Abramowicz; J L Vanherweghem; M Goldman
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

4.  Automated assay of N-acetyl-beta-glucosaminidase in normal and pathological human urine.

Authors:  S M Tucker; P J Boyd; A E Thompson; R G Price
Journal:  Clin Chim Acta       Date:  1975-07-23       Impact factor: 3.786

5.  Effects of glutathione depletion on the cytotoxic actions of cadmium in LLC-PK1 cells.

Authors:  W C Prozialeck; P C Lamar
Journal:  Toxicol Appl Pharmacol       Date:  1995-10       Impact factor: 4.219

6.  Continuous-flow system for automation of latex immunoassay by particle counting.

Authors:  A M Bernard; R R Lauwerys
Journal:  Clin Chem       Date:  1983-06       Impact factor: 8.327

7.  Inhibition of glutathione peroxidase by cadmium and other metal ions.

Authors:  A G Splittgerber; A L Tappel
Journal:  Arch Biochem Biophys       Date:  1979-10-15       Impact factor: 4.013

8.  Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney.

Authors:  W W Schulz; H K Hagler; L M Buja; E G Erdös
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

9.  Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody.

Authors:  P Ronco; H Pollard; M Galceran; M Delauche; J C Schwartz; P Verroust
Journal:  Lab Invest       Date:  1988-02       Impact factor: 5.662

10.  Health significance of cadmium induced renal dysfunction: a five year follow up.

Authors:  H A Roels; R R Lauwerys; J P Buchet; A M Bernard; A Vos; M Oversteyns
Journal:  Br J Ind Med       Date:  1989-11
View more
  3 in total

1.  Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Melissa A Lyle; Seethalakshmi R Iyer; Margaret M Redfield; Yogesh N V Reddy; G Michael Felker; Thomas P Cappola; Adrian F Hernandez; Christopher G Scott; John C Burnett; Naveen L Pereira
Journal:  JACC Heart Fail       Date:  2019-08-07       Impact factor: 12.035

2.  Cadmium in blood and urine--impact of sex, age, dietary intake, iron status, and former smoking--association of renal effects.

Authors:  Ing-Marie Olsson; Inger Bensryd; Thomas Lundh; Helena Ottosson; Staffan Skerfving; Agneta Oskarsson
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

3.  Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease.

Authors:  Yogesh N V Reddy; Seethalakshmi R Iyer; Christopher G Scott; Richard J Rodeheffer; Kent Bailey; Gregory Jenkins; Anthony Batzler; Margaret M Redfield; John C Burnett; Naveen L Pereira
Journal:  J Am Heart Assoc       Date:  2019-07-26       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.